EXT1 and acute lymphoblastic leukemia: A study by Liu et al. pointed to the fact that high EXT1 levels act anti-proliferatively, in reference to clinical data of patients with acute lymphocytic leukaemia correlating low EXT1 levels with a bad prognosis [18].